Sökning: onr:"swepub:oai:DiVA.org:oru-111588" >
IMPAIRED HEALTH-REL...
IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES : A CROSS-SECTIONAL ANALYSIS FROM AN INTERNATIONAL SURVEY
-
- Yoshida, A. (författare)
- Nippon Medical School Graduate School of Medicine, Department of Allergy and Rheumatology, Tokyo, Japan
-
- Li, Y. (författare)
- School of Public Health, University of Texas Health Science Center at Houston, Department of Biostatistics and Data Science, Houston TX, United States of America
-
- Maroufy, V. (författare)
- School of Public Health, University of Texas Health Science Center at Houston, Department of Biostatistics and Data Science, Houston TX, United States of America
-
visa fler...
-
- Kuwana, M. (författare)
- Nippon Medical School Graduate School of Medicine, Department of Allergy and Rheumatology, Tokyo, Japan
-
- Ravichandran, N. (författare)
- Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Lucknow, India
-
- Makol, A. (författare)
- Mayo Clinic, Division of Rheumatology, Rochester Minnesota, United States of America
-
- Sen, P. (författare)
- Maulana Azad Medical College, New Delhi, India
-
- Lilleker, J. B. (författare)
- The University of Manchester, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Manchester, United Kingdom; Northern Care Alliance NHS Foundation Trust, Neurology, Manchester Centre for Clinical Neurosciences, Salford, United Kingdom
-
- Agarwal, V. (författare)
- Mahatma Gandhi Mission Medical College, Navi Mumbai, Maharashtra, India
-
- Kardes, S. (författare)
- Istanbul University, Department of Medical Ecology and Hydroclimatology, Istanbul Faculty of Medicine, Istanbul, Turkey
-
- Day, J. (författare)
- Royal Melbourne Hospital, Department of Rheumatology, Parkville, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia; University of Melbourne, Department of Medical Biology, Parkville, Australia
-
- Milchert, M. (författare)
- Pomeranian Medical University in Szczecin, Department of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology, Szczecin, Poland
-
- Joshi, M. (författare)
- Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India
-
- Gheita, T. A. (författare)
- Cairo University, Rheumatology Department, Kasr Al Ainy School of Medicine, Cairo, Egypt
-
- Salim, B. (författare)
- Fauji Foundation Hospital, Rheumatology Department, Rawalpindi, Pakistan
-
- Velikova, T. (författare)
- University Hospital “Lozenetz”, Sofia University St. Kliment Ohridski, Department of Clinical Immunology, Medical Faculty, Sofia, Bulgaria
-
- Gracia-Ramos, A. E. (författare)
- General Hospital, National Medical Center “La Raza”, Instituto Mexicano del Seguro Social, Department of Internal Medicine, Mexico City, Mexico
-
- Parodis, Ioannis, 1981- (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden; Örebro University, Department of Rheumatology, Faculty of Medicine and Health, Örebro, Sweden
-
- Nikiphorou, E. (författare)
- King’s College London, Centre for Rheumatic Diseases, London, United Kingdom; King’s College Hospital, Rheumatology Department, London, United Kingdom
-
- Tan, A. L. (författare)
- Leeds Teaching Hospitals Trust, NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom; University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom
-
- Nune, A. (författare)
- Southport and Ormskirk Hospital NHS Trust, Southport, United Kingdom
-
- Cavagna, L. (författare)
- Fondazione I.R.C.C.S. Policlinico San Matteo, Department of Rheumatology, Pavia, Italy; Università degli studi di Pavia, Rheumatology Unit, Dipartimento di Medicine Interna e Terapia Medica, Pavia, Italy
-
- Saavedra, M. A. (författare)
- Centro Médico Nacional La Raza, IMSS, Departamento de Reumatología Hospital de Especialidades Dr. Antonio Fraga Mouret, Mexico City, Mexico
-
- Katsuyuki Shinjo, S. (författare)
- Universidade de Sao Paulo, Division of Rheumatology, Faculdade de Medicina FMUSP, Sao Paulo, Brazil
-
- Ziade, N. (författare)
- Saint- Joseph University, Rheumatology Department, Beirut, Lebanon; Hotel- Dieu de France Hospital, Rheumatology Department, Beirut, Lebanon
-
- Knitza, J. (författare)
- Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen- Nürnberg, Medizinische Klinik 3 - Rheumatologie und Immunologie, Erlangen, Germany
-
- Distler, O. (författare)
- University Hospital Zurich, University of Zurich, Department of Rheumatology, Zurich, Switzerland
-
- Chinoy, H. (författare)
- The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, Manchester, United Kingdom; The University of Manchester, National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom; Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Department of Rheumatology, Salford, United Kingdom
-
- Aggarwal, R. (författare)
- University of Pittsburgh School of Medicine, Division of Rheumatology and Clinical Immunology, Pittsburgh, Pennsylvania, United States of America
-
- Gupta, L. (författare)
- Sanjay Gandhi Postgraduate Institute of Medical Sciences, Department of Clinical Immunology and Rheumatology, Lucknow, India; The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, Manchester, United Kingdom; Royal Wolverhampton Hospitals NHS Trust, Department of Rheumatology, Wolverhampton, United Kingdom; City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom
-
visa färre...
-
(creator_code:org_t)
- HighWire Press, 2023
- 2023
- Engelska.
-
Ingår i: Annals of the Rheumatic Diseases. - : HighWire Press. - 0003-4967 .- 1468-2060. ; 82:Suppl. 1, s. 952-953
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Comprehensive and large-scale assessment of health-related quality of life in patients with idiopathic inflammatory myopathies (IIMs) worldwide is lacking. The second COVID-19 vaccination in autoimmune disease (COVAD-2) study [1] is an international, multicentre, self-reported e-survey assessing several aspects of COVID-19 infection and vaccination as well as validated patient-reported outcome measures (PROMs) to outline patient experience in various autoimmune diseases (AIDs), with a particular focus on IIMs.Objectives: To investigate physical and mental health in a global cohort of IIM patients compared to those with non-IIM autoimmune inflammatory rheumatic diseases (AIRDs), non-rheumatic AIDs (NRAIDs), and those without AIDs (controls), using Patient-Reported Outcome Measurement Information System (PROMIS) global health data obtained from the COVAD-2 survey.Methods: Demographics, AID diagnoses, comorbidities, disease activity, treatments, and PROMs were extracted from the COVAD-2 database. The primary outcomes were PROMIS Global Physical Health (GPH) and Global Mental Health (GMH) scores. Secondary outcomes included PROMIS physical function short form-10a (PROMIS PF-10a), pain visual analogue scale (VAS), and PROMIS Fatigue-4a scores. Each outcome was compared between IIMs, non-IIM AIRDs, NRAIDs, and controls. Factors affecting GPH and GMH scores in IIMs were identified using multivariable regression analysis.Results: A total of 10,502 complete responses from 1582 IIMs, 4700 non-IIM AIRDs, 545 NRAIDs, and 3675 controls, which accrued as of May 2022, were analysed. Patients with IIMs were older [59±14 (IIMs) vs. 48±14 (non-IIM AIRDs) vs. 45±14 (NRAIDs) vs. 40±14 (controls) years, p<0.001] and more likely to be Caucasian [82.7% (IIMs) vs. 53.2% (non-IIM AIRDs) vs. 62.4% (NRAIDs) vs. 34.5% (controls), p<0.001]. Among IIMs, dermatomyositis (DM) and juvenile DM were the most common (31.4%), followed by inclusion body myositis (IBM) (24.9%). Patients with IIMs were more likely to have comorbidities [68.1% (IIMs) vs. 45.7% (non-IIM AIRDs) vs. 45.1% (NRAIDs) vs. 26.3% (controls), p<0.001] including mental disorders [33.4% (IIMs) vs. 28.2% (non-IIM AIRDs) vs. 28.4% (NRAIDs) vs. 17.9% (controls), p<0.001].GPH median scores were lower in IIMs compared to NRAIDs or controls [13 (interquartile range 10–15) IIMs vs. 13 (11–15) non-IIM AIRDs vs. 15 (13–17) NRAIDs vs. 17 (15–18) controls, p<0.001] and PROMIS PF-10a median scores were the lowest in IIMs [34 (25–43) IIMs vs. 40 (34–46) non-IIM AIRDs vs. 47 (40–50) NRAIDs vs. 49 (45–50) controls, p<0.001]. GMH median scores were lower in AIDs including IIMs compared to controls [13 (10–15) IIMs vs. 13 (10–15) non-IIM AIRDs vs. 13 (11–16) NRAIDs vs. 15 (13–17) controls, p<0.001]. Pain VAS median scores were higher in AIDs compared to controls [3 (1–5) IIMs vs. 4 (2–6) non-IIM AIRDs vs. 2 (0–4) NRAIDs vs. 0 (0–2) controls, p<0.001]. Of note, PROMIS Fatigue-4a median scores were the highest in IIMs [11 (8–14) IIMs vs. 8 (10–14) non-IIM AIRDs vs. 9 (7–13) NRAIDs vs. 7 (4–10) controls, p<0.001].Multivariable regression analysis in IIMs identified older age, male sex, IBM, comorbidities including hypertension and diabetes, active disease, glucocorticoid use, increased pain and fatigue as the independent factors for lower GPH scores, whereas coexistence of interstitial lung disease, mental disorders including anxiety disorder and depression, active disease, increased pain and fatigue were the independent factors for lower GMH scores.Conclusion: Both physical and mental health are significantly impaired in patients with IIMs compared to those with non-IIM AIDs or those without AIDs. Our results call for greater attention to patient-reported experience and comorbidities including mental disorders to provide targeted approaches and optimise global well-being in patients with IIMs.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)
Nyckelord
- Patient reported outcomes
- Myositis
- Quality of life
Publikations- och innehållstyp
- vet (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Yoshida, A.
-
Li, Y.
-
Maroufy, V.
-
Kuwana, M.
-
Ravichandran, N.
-
Makol, A.
-
visa fler...
-
Sen, P.
-
Lilleker, J. B.
-
Agarwal, V.
-
Kardes, S.
-
Day, J.
-
Milchert, M.
-
Joshi, M.
-
Gheita, T. A.
-
Salim, B.
-
Velikova, T.
-
Gracia-Ramos, A. ...
-
Parodis, Ioannis ...
-
Nikiphorou, E.
-
Tan, A. L.
-
Nune, A.
-
Cavagna, L.
-
Saavedra, M. A.
-
Katsuyuki Shinjo ...
-
Ziade, N.
-
Knitza, J.
-
Distler, O.
-
Chinoy, H.
-
Aggarwal, R.
-
Gupta, L.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Reumatologi och ...
- Artiklar i publikationen
-
Annals of the Rh ...
- Av lärosätet
-
Örebro universitet
-
Karolinska Institutet